The Biden administration has invoked the Defense Production Act to expedite the rebuilding of Baxter International’s IV fluid facility, where production was halted in the wake of flooding following Hurricane Helene, CBS News reported Oct. 15.
Category: Supply Chain
20 tips for hospitals amid IV, peritoneal dialysis solution shortage
After Hurricane Helene struck Baxter’s site in North Cove facility in Marion, N.C. — the nation’s main manufacturer of intravenous and peritoneal dialysis solutions — several healthcare organizations have shared conservation and drug shortage mitigatio…
IV shortage: 5 key updates for ASCs
Hurricane Helene damaged a Baxter plant in Marion, N.C., that makes 60% of the nation’s IV fluid products, in September, and hospitals are struggling amid the shortages.
Baxter imports IV fluids to relieve US shortages
Baxter International started to import IV fluids last week from two of its international manufacturing facilities to address supply shortages in the U.S.
Kaweah Health signs Medline as prime vendor
Medline has signed a multi-year prime vendor distribution agreement with Visalia, Calif.-based Kaweah Health, California’s largest community healthcare organization which operates over 600 beds.
CDC issues guidelines for IV, PD fluid shortage
The CDC issued a health advisory Oct. 12 with guidelines on how systems and leaders can manage the supply disruptions of peritoneal dialysis and intravenous solutions.
Health system strategies to mitigate the IV shortage: What to know
Hospitals and health systems nationwide are implementing conservation strategies and exploring alternatives to address the national shortage of IV fluids.
Daytona Beach IV plant survives Hurricane Milton
Daytona Beach, Fla.-based B. Braun Medical plant, which produces nearly one-quarter of the IV fluids in the U.S., has emerged unscathed following Hurricane Milton, The New York Times reported Oct. 10.
The IV supply crisis: What ASCs need to know
Amid the fallout from Hurricane Helene, hospitals across the nation are conserving IV fluids.
FDA set to allow temporary importation of IV products: 6 shortage updates
The FDA may move to allow the temporary importation of intravenous fluids and related products from overseas manufacturing sites to address critical shortages exacerbated by Hurricane Helene, the agency told Becker’s Oct. 9.
